rdf:type |
|
lifeskim:mentions |
umls-concept:C0001455,
umls-concept:C0002335,
umls-concept:C0030847,
umls-concept:C0031640,
umls-concept:C0073561,
umls-concept:C0205195,
umls-concept:C0279023,
umls-concept:C0332307,
umls-concept:C0871261,
umls-concept:C1149866,
umls-concept:C1412691,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1849508,
umls-concept:C1999216,
umls-concept:C2911692
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-11-24
|
pubmed:abstractText |
Phosphodiesterases (PDEs) are an important component of the signal transduction pathway during the erectile response. To determine the PDE isoforms in the corpora cavernosa in the cat and to establish the functional presence of PDE 4 in human cavernosal tissue, the erectile response to intracavernosal phosphodiesterase (PDE) inhibitors alone and the combination of PDE inhibitors and prostaglandin E1 (PGE1) was evaluated in the anesthetized cat. The in vitro formation of cAMP and cGMP in human cavernosal smooth muscle cells (HCSMCs) treated with PGE1 and rolipram in primary culture was also measured.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-5347
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1848-55
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10524946-Alprostadil,
pubmed-meshheading:10524946-Animals,
pubmed-meshheading:10524946-Cats,
pubmed-meshheading:10524946-Cells, Cultured,
pubmed-meshheading:10524946-Cyclic AMP,
pubmed-meshheading:10524946-Cyclic GMP,
pubmed-meshheading:10524946-Dose-Response Relationship, Drug,
pubmed-meshheading:10524946-Male,
pubmed-meshheading:10524946-Milrinone,
pubmed-meshheading:10524946-Penile Erection,
pubmed-meshheading:10524946-Penis,
pubmed-meshheading:10524946-Phosphodiesterase Inhibitors,
pubmed-meshheading:10524946-Purinones,
pubmed-meshheading:10524946-Rolipram
|
pubmed:year |
1999
|
pubmed:articleTitle |
Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
|
pubmed:affiliation |
Department of Urology, Tulane University Medical School, New Orleans, Louisiana 70112, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|